ID

34290

Descripción

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01831765

Link

https://clinicaltrials.gov/show/NCT01831765

Palabras clave

  1. 16/01/2019 16/01/2019 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

16 janvier 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01831765

Eligibility Diabetes NCT01831765

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01831765
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 1 diabetes (diagnosed clinically) for 12 months or longer at the time of screening (visit 1)
Descripción

ID.1

Tipo de datos

boolean

currently treated with a basal-bolus insulin regimen for at least 12 months prior to screening (visit 1)
Descripción

ID.2

Tipo de datos

boolean

currently treated with a basal insulin analogue (any regimen of insulin detemir or insulin glargine) for at least 4 months prior to screening (visit 1)
Descripción

ID.3

Tipo de datos

boolean

hba1c 7.0-9.5% (53-80 mmol/mol) (both inclusive) as assessed by central laboratory
Descripción

ID.4

Tipo de datos

boolean

body mass index (bmi) below or equal to 35.0 kg/m^2
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of any anti-diabetic drug other than insulin within the last 3 months prior to screening (visit 1)
Descripción

ID.6

Tipo de datos

boolean

recurrent severe hypoglycaemia (more than one severe hypoglycaemic event during the last 12 months) or hypoglycaemic unawareness as judged by the investigator, or hospitalisation for diabetic ketoacidosis during the previous 6 months prior to screening (visit 1)
Descripción

ID.7

Tipo de datos

boolean

cardiovascular disease, within the last 6 months prior to screening (visit 1), defined as stroke, decompensated heart failure new york heart association (nyha) class iii or iv, myocardial infarction, unstable angina pectoris, coronary arterial bypass graft or angioplasty
Descripción

ID.8

Tipo de datos

boolean

Similar models

Eligibility Diabetes NCT01831765

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01831765
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
type 1 diabetes (diagnosed clinically) for 12 months or longer at the time of screening (visit 1)
boolean
ID.2
Item
currently treated with a basal-bolus insulin regimen for at least 12 months prior to screening (visit 1)
boolean
ID.3
Item
currently treated with a basal insulin analogue (any regimen of insulin detemir or insulin glargine) for at least 4 months prior to screening (visit 1)
boolean
ID.4
Item
hba1c 7.0-9.5% (53-80 mmol/mol) (both inclusive) as assessed by central laboratory
boolean
ID.5
Item
body mass index (bmi) below or equal to 35.0 kg/m^2
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
use of any anti-diabetic drug other than insulin within the last 3 months prior to screening (visit 1)
boolean
ID.7
Item
recurrent severe hypoglycaemia (more than one severe hypoglycaemic event during the last 12 months) or hypoglycaemic unawareness as judged by the investigator, or hospitalisation for diabetic ketoacidosis during the previous 6 months prior to screening (visit 1)
boolean
ID.8
Item
cardiovascular disease, within the last 6 months prior to screening (visit 1), defined as stroke, decompensated heart failure new york heart association (nyha) class iii or iv, myocardial infarction, unstable angina pectoris, coronary arterial bypass graft or angioplasty
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial